Cottage Cheese

Cottage cheese has experienced a significant nutritional rehabilitation in recent years, and for GLP-1 users it is one of the most strategic dairy proteins available. A 100-gram serving of low-fat cottage cheese provides 11 grams of protein at just 98 calories. What distinguishes it from other dairy proteins is the type of protein it contains: cottage cheese is primarily casein, a slow-digesting protein that forms a gel in the stomach and releases amino acids steadily over four to six hours. For GLP-1 users managing appetite suppression and trying to maintain muscle mass across a day with fewer total meals, slow-release protein is distinctly advantageous. Casein's gel-forming property in the stomach also contributes directly to satiety in a way that complements the medication's own gastric-slowing mechanism. While GLP-1 drugs extend fullness through delayed gastric emptying, the casein matrix provides an additional satiety signal that can bridge the gap between eating occasions without requiring additional calories. Cottage cheese is also one of the most versatile high-protein foods in a GLP-1 eating plan. It can be eaten plain, blended into smoothies for a creamy texture, used as a ricotta substitute in savory dishes, or mixed with berries for a protein-rich dessert alternative. Its mild flavor makes it approachable even for users experiencing altered taste perception, which some report during GLP-1 therapy. From a micronutrient perspective, cottage cheese delivers calcium, phosphorus, selenium, and B12 — all relevant for bone health and metabolic function during calorie restriction. The sodium content in commercial varieties (350-500mg per 100g) is worth monitoring for users managing blood pressure alongside weight, but low-sodium versions are widely available. At roughly $3 to $5 per 16-oz container providing eight to ten servings, it competes with chicken breast as one of the most cost-effective complete proteins.